AIG
TNGX icon

American International Group’s Tango Therapeutics TNGX Stock Holding History

American International Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,001
Closed -$175K – 2486
2024
Q1 		$175K Sell
22,001
-189
-0.9% -$2.03K ﹤0.01% 2227
2023
Q4 		$220K Sell
22,190
-89
-0.4% -$773 ﹤0.01% 2125
2023
Q3 		$251K Buy
22,279
+792
+4% +$4.83K ﹤0.01% 1993
2023
Q2 		$71.3K Sell
21,487
-1,020
-5% -$3.67K ﹤0.01% 2766
2023
Q1 		$88.9K Buy
22,507
+447
+2% +$2.59K ﹤0.01% 2513
2022
Q4 		$160K Sell
22,060
-81
-0.4% -$570 ﹤0.01% 2260
2022
Q3 		$80K Buy
22,141
+313
+1% +$1.34K ﹤0.01% 2659
2022
Q2 		$99K Buy
+21,828
New +$132K ﹤0.01% 2606

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

American International Group's TNGX Position: Q2 2024 in Review

American International Group sold out of Tango Therapeutics (TNGX) in Q2 2024, closing a stake of 22,001 shares — an estimated $175K sold.

American International Group first reported a position in TNGX in Q2 2022 and held it in 8 quarters. The position peaked at $251K in Q3 2023. 119 funds tracked by Wall St. Rank hold TNGX as of Q2 2024.

  • American International Group reported no remaining Tango Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 22,001 Tango Therapeutics shares in Q2 2024, an estimated $175K.
  • American International Group first reported a position in Tango Therapeutics in Q2 2022 and held it in 8 quarters.
  • American International Group's Tango Therapeutics position peaked at $251K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.